+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Guerbet SA (GBT) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 52 Pages
  • December 2022
  • GlobalData
  • ID: 2705091
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Guerbet SA (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Guerbet SA (Guerbet) is a manufacturer of contrast agents. The company provides a wide range of imaging products, solutions, and services for Computed Tomography (CT)/Cath Lab examinations, magnetic resonance imaging (MRI), and interventional imaging. CT/Cath Lab contrast agents consist of iodinated active ingredients, and few examinations of the digestive tract use barium-based products. MRI imaging uses gadolinium complexes. Guerbet has a presence in Europe, Asia, and North and South America. The company offers products directly through its sales structure, distributors, and license holders. Guerbet is headquartered in Villepinte, France.

Guerbet SA Key Recent Developments

  • Oct 20, 2022: Guerbet Revenue at September 30, 2022
  • Apr 21, 2022: Guerbet: Q1 2022 revenue
  • Apr 06, 2022: Guerbet strengthens its Executive Committee with the appointment of Charlotte Bamière, General Counsel
  • Mar 23, 2022: Guerbet Announces 2021 annual results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Guerbet SA - Key Facts
  • Guerbet SA - Key Employees
  • Guerbet SA - Key Employee Biographies
  • Guerbet SA - Major Products and Services
  • Guerbet SA - History
  • Guerbet SA - Company Statement
  • Guerbet SA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Guerbet SA - Business Description
  • Business Segment: Diagnostic Imaging
  • Overview
  • Performance
  • Business Segment: Interventional Imaging
  • Overview
  • Performance
  • Geographical Segment: European Markets
  • Performance
  • Geographical Segment: Other Markets
  • Performance
  • R&D Overview
  • Guerbet SA - Corporate Strategy
  • Guerbet SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Guerbet SA - Strengths
  • Guerbet SA - Weaknesses
  • Guerbet SA - Opportunities
  • Guerbet SA - Threats
  • Guerbet SA - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Guerbet SA, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Guerbet SA, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • Guerbet SA, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Oct 20, 2022: Guerbet Revenue at September 30, 2022
  • Apr 21, 2022: Guerbet: Q1 2022 revenue
  • Apr 06, 2022: Guerbet strengthens its Executive Committee with the appointment of Charlotte Bamière, General Counsel
  • Mar 23, 2022: Guerbet Announces 2021 annual results
  • Oct 21, 2021: Guerbet Revenue at September 30, 2021
  • Sep 22, 2021: Guerbet Announces consolidated results for the first half of 2021
  • May 31, 2021: Marc Massiot appointed to Guerbet’s Board of Directors
  • Mar 24, 2021: Guerbet announces 2020 annual results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Guerbet SA, Key Facts
  • Guerbet SA, Key Employees
  • Guerbet SA, Key Employee Biographies
  • Guerbet SA, Major Products and Services
  • Guerbet SA, History
  • Guerbet SA, Other Locations
  • Guerbet SA, Subsidiaries
  • Guerbet SA, Key Competitors
  • Guerbet SA, Annual Ratios
  • Guerbet SA, Interim Ratios
  • Guerbet SA, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Guerbet SA, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • Guerbet SA, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Guerbet SA, Performance Chart (2017 - 2021)
  • Guerbet SA, Ratio Charts
  • Guerbet SA, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Guerbet SA, Medical Equipment, Deals by Type, 2016 to YTD 2022

Samples

Loading
LOADING...

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Terumo BCT Inc
  • SuperSonic Imagine SA
  • Sirtex Medical Europe GmbH
  • Boston Scientific Corp
  • Merit Medical Systems Inc
  • GE Healthcare
  • Bayer AG
  • Medtron AG
  • Nemoto Kyorindo Co Ltd
  • ulrich GmbH & Co KG
  • Bracco Imaging France SAS